Based on interview and record review, the facility failed to ensure that 2 of 5 residents (Resident (R) 32 and R35) sampled for unnecessary medications were free from chemical restraints. This was evidenced by no follow-up by the facility regarding the Consultant Pharmacist (CPH) 1's recommendation to provide a specific stop date/time period and a clinical rationale to continue an as needed (prn) psychotropic medication (Lorazepam) past 14 days for R32, no documentation of checking with the physician to taper the dose for an antipsychotic medication (Seroquel) that was ordered routinely for R32, no record of any side effects monitoring for psychoactive medication (Citalopram) ordered routinely for R35, and antipsychotic (Quetiapine) was ordered prn for greater than 14 days for R35. …
F605 citations in Hawaii
Freedom from Abuse, Neglect, and Exploitation Deficiencies
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
No F605 citations were recorded in Hawaii for 2025. That means none appear in the CMS file for that year — not that the requirement does not apply.
In the surveyor’s words
What Hawaii surveyors wrote
F605 findings written in Hawaii, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Hawaii surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction